Experts discuss the current status of neoadjuvant ADC therapies, eligibility criteria, and future treatment pathways for high-risk patients.

Sarah Anderson, oncology strategy lead director, Novotech, discusses the growing prominence of triple-negative breast cancer clinical trials in the Asia-Pacific region, and the significant investments ...

SYDNEY--(BUSINESS WIRE)--Novotech, the leading global full-service clinical Contract Research Organization (CRO), has released a comprehensive report analyzing the global clinical trial and drug ...

An expert shares information on a pair of noteworthy active trials in breast cancer that patients should be aware of. For patients with triple-negative breast cancer, there are now several clinical ...

Many people are surprised to learn that clinical trials aren't just for people who have run out of standard treatment options ...

When you think of clinical trials for cancer, testing a new medication may come to mind. But drugs aren’t the only thing these trials investigate. There’s a growing world of nonpharmaceutical clinical ...

Colorectal cancer (CRC) remains one of the most prevalent and lethal malignancies worldwide, representing a major challenge ...

Peptinovo Biopharma, an Ann Arbor-based biotechnology company pioneering targeted cancer therapies through its first-of-its-kind proprietary PALM™ nanotechnology, today announced it has received ...

Many clinical trials include a placebo group—participants who receive an inactive treatment—so researchers can compare ...

Despite the many benefits of clinical trials, misconceptions still exist. Get the facts, so you can make an informed choice about whether applying for a trial is right for you. Whether you are at the ...

In " Beyond Diagnosis: Breast Cancer," Cleveland Clinic oncologist Tiffany Onger, MD, and host John Mangels continue their ...